| Name |
Colospa retard 200 mg kapsule s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-164323096 |
| Active Substance |
mebeverinklorid |
| Composition |
jedna kapsula s produljenim oslobađanjem sadrži 200 mg mebeverinklorida |
| Pharmaceutical Form |
kapsula s produljenim oslobađanjem, tvrda |
| Manufacturer |
Mylan Laboratories SAS, Châtillon-sur-Chalaronne, Francuska |
| Marketing Authorisation Holder |
Viatris Hrvatska d.o.o., Koranska 2, Zagreb, Hrvatska |
| Marketing Authorisation Date |
05.09.2019 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/573 |
| Registration Number |
381-12-01/70-19-07 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
A03AA04 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
